CytoSorbents Corporation

CytoSorbents Corporation is a global leader in developing and commercializing innovative blood purification technologies. The company's flagship product, CytoSorb, is a hemoadsorption therapy that effectively removes excessive levels of toxins and inflammatory mediators from the blood. CytoSorb is used in a variety of critical care settings, including sepsis, liver failure, trauma, and lung injury. The company is also developing a number of other products, including PuriFi, a standalone hemoadsorption platform, and ECOS, a sorbent cartridge designed for ex vivo organ perfusion.

CytoSorbents is committed to improving patient outcomes through its innovative technologies. The company has a strong track record of research and development, and its products are supported by a growing body of clinical evidence. CytoSorbents is also committed to providing excellent customer service and support to its healthcare partners.

CytoSorbents Corporation prioritizes work-life balance, striving to create an environment where employees feel valued and supported. This is reflected in their commitment to providing flexibility, allowing employees to find a balance between their professional and personal lives.

CytoSorbents offers a competitive benefits package that includes stock option grants, paid time off, and wellness perks. They strive to create a work environment that prioritizes a healthy work-life balance and provides employees with modern working equipment and 24/7 technical support.

CytoSorbents Corporation is a global medical device company dedicated to expanding the dimensions of blood purification with a focus on removing excessive levels of harmful substances that are not easily removed by dialysis. The company is committed to developing and commercializing innovative therapies that help healthcare professionals restore balance and control damage in critical care, cardiovascular, liver, and kidney settings. CytoSorbents prioritizes evidence-based research, partnering with renowned scientists and institutions, and strives to provide customized training and support to healthcare professionals globally, enabling them to deliver the best possible care to their patients.

CytoSorbents promotes a culture of collaboration, innovation, and commitment to saving lives. They value diversity and embrace a global perspective, with employees representing 26 nationalities from 16 countries. This diversity allows for a wide range of insights and ideas, ultimately leading to transformative advancements in medicine. The company prioritizes a positive and supportive work environment that fosters a sense of teamwork and encourages personal growth. They offer a competitive benefits package including stock options, paid time off, and wellness perks, demonstrating their commitment to employee well-being.

CytoSorbents Corporation values diversity, equity, and inclusion as crucial drivers of innovation. With employees representing 26 nationalities from 16 countries, the company fosters a global workforce with a variety of perspectives, cultures, and experiences. This diversity is seen as a strength, enabling the harnessing of a wide range of insights and ideas to advance medical technology. The company strives to create a workplace where all employees feel valued and respected, with a focus on inclusivity and a commitment to creating a culture of collaboration.